These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 38410

  • 21. Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease.
    Grzegorzewska AE, Młot M.
    Rocz Akad Med Bialymst; 2004; 49():190-2. PubMed ID: 15631341
    [Abstract] [Full Text] [Related]

  • 22. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
    Yang WS, Kim SB, Min WK, Park S, Lee MS, Park JS.
    Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
    [Abstract] [Full Text] [Related]

  • 23. [Bone isoenzyme fraction of alkaline phosphatase in patients undergoing prolonged hemodialysis treatment].
    Bunkova M, Kuleva V.
    Vutr Boles; 1978; 17(2):86-9. PubMed ID: 654237
    [Abstract] [Full Text] [Related]

  • 24. An assessment of dialysis-associated osteodystrophy in long-term peritoneal dialysis.
    Hemmeløff Andersen KE, Bengsgaard Pedersen F, Hørder M.
    Nephron; 1982; 30(4):328-32. PubMed ID: 7110463
    [Abstract] [Full Text] [Related]

  • 25. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P.
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [Abstract] [Full Text] [Related]

  • 26. Skeletal complications of renal insufficiency and maintenance haemodialysis.
    Ritz E, Krempien B, Mehls O, Mallushe H, Strobel Z, Zimmermann H.
    Nephron; 1973; 10(2):195-207. PubMed ID: 4710980
    [No Abstract] [Full Text] [Related]

  • 27. Misclassification of calcium status in end-stage kidney disease using albumin-adjusted calcium levels.
    Law MM, Smith JD, Schneider HG, Wilson S.
    Nephrology (Carlton); 2021 Sep; 26(9):725-732. PubMed ID: 34089212
    [Abstract] [Full Text] [Related]

  • 28. Study of the relationships between pericarditis and osteopathy in chronic haemodialysis.
    Makó J, Szücs J, Gaizler G, Lengyel M, Mérei J.
    Int Urol Nephrol; 1983 Sep; 15(4):383-7. PubMed ID: 6662655
    [Abstract] [Full Text] [Related]

  • 29. Comparison of serum calcium fractions during haemodialysis and peritoneal dialysis.
    Kelly PM, Bending MR, Barron JL.
    Ann Clin Biochem; 1987 Nov; 24 ( Pt 6)():585-90. PubMed ID: 3426125
    [Abstract] [Full Text] [Related]

  • 30. The source and clinical significance of serum alkaline phosphatases in patients treated by chronic dialysis.
    Stĕpán J, Pilarová T, Melicharová D.
    Acta Univ Carol Med Monogr; 1977 Nov; (78 Pt 2):75-9. PubMed ID: 615470
    [Abstract] [Full Text] [Related]

  • 31. Letter: Serum-alkaline-phosphatase during maintenance haemodialysis.
    Stepán J, Pilarova T.
    Lancet; 1975 May 24; 1(7917):1188-9. PubMed ID: 48800
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience.
    Tsai WC, Peng YS, Yang JY, Hsu SP, Wu HY, Pai MF, Chang JF, Chen HY.
    Blood Purif; 2013 May 24; 36(2):116-21. PubMed ID: 24217122
    [Abstract] [Full Text] [Related]

  • 35. Letter: Maintenance haemodialysis.
    Eastwood JB, Curtis JR, Gower PE, Roberts AP, De Wardener HE.
    Lancet; 1974 Mar 02; 1(7853):365-6. PubMed ID: 4131223
    [No Abstract] [Full Text] [Related]

  • 36. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM, Youssef AM, Zayoon MY.
    Hemodial Int; 2006 Oct 02; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [Abstract] [Full Text] [Related]

  • 37. [Ionized calcium during hemodialysis in chronic renal insufficiency].
    Sachs C, Bourdeau AM, Broyer M, Balsan S.
    Ann Biol Clin (Paris); 1970 Oct 02; 28(2):137-43. PubMed ID: 5450914
    [No Abstract] [Full Text] [Related]

  • 38. [The mineral content of bone and the activity of alkaline bone phosphatase in renal bone disease treated with dialysis and after kidney transplantation].
    Koall W, Mampel E, Hintner I, Runge H.
    Z Gesamte Inn Med; 1978 Jun 15; 33(12):403-6. PubMed ID: 356443
    [No Abstract] [Full Text] [Related]

  • 39. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
    Yamada S, Ueki K, Tokumoto M, Suehiro T, Kimura H, Taniguchi M, Fujimi S, Kitazono T, Tsuruya K.
    Ther Apher Dial; 2016 Feb 15; 20(1):31-9. PubMed ID: 26482334
    [Abstract] [Full Text] [Related]

  • 40. An evaluation of 1-84 PTH measurement in relation to bone alkaline phosphatase and bone Gla protein in hemodialysis patients.
    Miwa N, Nitta K, Kimata N, Watanabe Y, Suzuki K, Kawashima A, Haga M, Watanabe R, Aoki T, Akiba T, Nihei H.
    Nephron Clin Pract; 2003 Feb 15; 94(2):c29-32. PubMed ID: 12845234
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.